This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baev, N. I. Articles by Macdonald, R. L. Search for Related Content PubMed PubMed Citation Articles by Baev, N. I. Articles by Macdonald, R. L. Pubmed/NCBI databases Medline Plus Health Information Arteriovenous Malformations Genetics Home Reference

(Stroke. 1998;29:2426-2434.)
© 1998 American Heart Association, Inc.

Original Contributions

Endothelial Cell Culture From Human Cerebral Cavernous Malformations

Nikolay I. Baev, MD, PhD; Issam A. Awad, MD, MS, FACS

From the Department of Neurosurgery, Yale University School of Medicine, New Haven, Conn.

Correspondence to Issam A. Awad, MD, MS, FACS, Department of Neurosurgery, Yale University School of Medicine, 333 Cedar St, TMP 405, PO Box 208082, New Haven, CT 06520-8082. E-mail issam.awad{at}yale.edu

Background and Purpose—The cerebral cavernous malformation (CCM) is a common and frequently unrecognized cause of stroke and epilepsy. It consists of blood-filled caverns lined by endothelial cells (EC) and devoid of mature vessel wall structure. Cultured EC obtained from CCM may express phenotypic and genotypic alterations contributing to CCM pathogenesis. We report the first successful isolation and growth in vitro of primary EC lines from human CCM lesions.

Methods—We developed a procedure for the isolation and growth of EC from human CCM, confirmed their EC origin by a panel of molecular markers, and determined by immunocytochemistry the basic expression patterns of 6 transmembrane receptor protein kinases comparing brain, skin, and CCM primary EC lines grown identically.

Results—Several CCM EC lines were established from 2 patients after we treated the excised specimens with 0.3% trypsin/1% EDTA, selective cloning, and growth in MCDB107 containing 0.3 g/L heparin, 0.15 g/L endothelial cell growth supplement, and 15% FBS. The CCM EC showed contact inhibition and a rounded cobblestone appearance. The cells expressed CD31, CD105, von Willebrand factor, and binding sites for Ulex europaeus agglutinin, type 1 and acetylated LDL. They showed low levels of Flt-1, Flk-1, transforming growth factor (TGF)-ß RI, and TGF-ß RII expression but stained strongly with antibodies against Tie-1 and Tie-2.

Conclusions—Cultured CCM EC retained their endothelial phenotype. Brain, skin, and CCM EC lines did not significantly differ in their staining patterns with antibodies against Flt-1, Flk-1, TGF-ß RI, TGF-ß RII, Tie-1, and Tie-2. These cell lines will assist in defining molecular phenotype and genotype alterations in association with CCM.

Editorial Comment

R. Loch Macdonald, MD, PhD, Guest Editor

Section of Neurosurgery University of Chicago Medical Center Chicago, Illinois

This article has been cited by other articles:

				Y. Zhao, Y.-Z. Tan, L.-F. Zhou, H.-J. Wang, and Y. Mao Morphological Observation and In Vitro Angiogenesis Assay of Endothelial Cells Isolated From Human Cerebral Cavernous Malformations Stroke, April 1, 2007; 38(4): 1313 - 1319. [Abstract] [Full Text] [PDF]

				J. E. Greening, T. I.M. Tree, K. T. Kotowicz, A. G. van Halteren, B. O. Roep, N. J. Klein, and M. Peakman Processing and Presentation of the Islet Autoantigen GAD by Vascular Endothelial Cells Promotes Transmigration of Autoreactive T-Cells Diabetes, March 1, 2003; 52(3): 717 - 725. [Abstract] [Full Text] [PDF]